{"entity":{"type":"insider","cik":"0002058197","url":"/insider/0002058197","json_url":"/insider/0002058197.json","name":"Apuli Maricel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2025-05-06","last":"2026-08-03","span_basis":"filed_date"},"name_variants":[{"name":"Apuli Maricel","source":"filing","n_filings":7,"first_seen":"2025-05-06","last_seen":"2026-08-03"}],"transactions":[{"id":5881263,"accession":"0001470831-26-000745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000745","line_url":"/filing/0001470831-26-000745#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":80.06,"price_display":"80.06","price_state":"stated","total_value":160120.0,"total_display":"160,120.00","total_whole":"160,120","shares_owned_after":127401.0,"shares_owned_after_display":"127,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-30","filed_date":"2026-08-03","scope":"insider"},{"id":5812871,"accession":"0001470831-26-000410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000410","line_url":"/filing/0001470831-26-000410#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":71.58,"price_display":"71.58","price_state":"stated","total_value":143160.0,"total_display":"143,160.00","total_whole":"143,160","shares_owned_after":134115.0,"shares_owned_after_display":"134,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-04","scope":"insider"},{"id":5783887,"accession":"0001470831-26-000225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000225","line_url":"/filing/0001470831-26-000225#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":66.0,"price_display":"66.00","price_state":"stated","total_value":132000.0,"total_display":"132,000.00","total_whole":"132,000","shares_owned_after":121945.0,"shares_owned_after_display":"121,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-26","filed_date":"2026-02-27","scope":"insider"},{"id":6185325,"accession":"0001470831-26-000186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000186","line_url":"/filing/0001470831-26-000186#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510.0,"shares_display":"510","price_per_share":74.31,"price_display":"74.31","price_state":"stated","total_value":37898.1,"total_display":"37,898.10","total_whole":"37,898","shares_owned_after":123945.0,"shares_owned_after_display":"123,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-18","scope":"insider"},{"id":4151641,"accession":"0001470831-25-000392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-25-000392","line_url":"/filing/0001470831-25-000392#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":74.26,"price_display":"74.26","price_state":"stated","total_value":148520.0,"total_display":"148,520.00","total_whole":"148,520","shares_owned_after":130297.0,"shares_owned_after_display":"130,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-08","filed_date":"2025-12-10","scope":"insider"},{"id":4378606,"accession":"0000950170-25-106751","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-106751","line_url":"/filing/0000950170-25-106751#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":45.44,"price_display":"45.44","price_state":"stated","total_value":45440.0,"total_display":"45,440.00","total_whole":"45,440","shares_owned_after":141859.0,"shares_owned_after_display":"141,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-08-11","scope":"insider"},{"id":5074719,"accession":"0000950170-25-064567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-064567","line_url":"/filing/0000950170-25-064567#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0002058197","owner_name":"Apuli Maricel","owner_display_name":"Apuli Maricel","owner_url":"/insider/0002058197","role":"Officer (Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1026.0,"shares_display":"1,026","price_per_share":38.5079,"price_display":"38.51","price_state":"stated","total_value":39509.1054,"total_display":"39,509.11","total_whole":"39,509","shares_owned_after":147639.0,"shares_owned_after_display":"147,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Officer (Chief Accounting Officer)","n_filings":7,"first_seen":"2025-05-06","last_seen":"2026-08-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002058197","retrieved_at":"2026-08-24T15:24:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}